Simulands

What Simulands does

Simulands AG is a Zurich-headquartered medical simulation company founded in 2019 that develops high-fidelity cardiovascular simulators used to train interventional cardiologists and to support medical-device OEMs during product launches. The company addresses a documented training gap in structural heart interventions—including TAVR, T-TEER, TMVR, LAAO, and transseptal puncture—by replacing or reducing reliance on animal models and high-risk patient training with human-grade simulators built from real patient CT and 3D echo datasets. Target customers are tertiary and quaternary cardiac centers, transcatheter-device manufacturers requiring sales-demonstration and human-factors validation tools, and medical education institutions building standardized procedural curricula.

The product platform is organized in four tiers: simuGO (ultra-portable travel-ready simulators for sales demos and field training with setup under 30 seconds), simuDRY (portable dry-environment platforms for targeted anatomic skills), simuSLICE (wet-lab beating-heart simulators with imaging-compatible leaflets and annular motion), and simuPULSE (full beating-heart systems with pulsatile hemodynamics, body-temperature control, and pressure-gradient generation across TAVI, mitral, tricuspid, access, and imaging configurations). All platforms use the proprietary simuTISSUE material (fluorogenic and echogenic under TEE, ICE, and fluoroscopy) and a growing disposables catalog of single-use valve leaflets, fossa inserts, and chambers. simuVISION adds an augmented-reality/metaverse training layer. Simulators are designed to ISO normative requirements with clinical and technical equivalence demonstrated against CE, FDA, and MDR standards.

Revenue is generated primarily through direct enterprise sales of simulator hardware and recurring consumables (single-use anatomical components) on custom multi-year contracts, supplemented by training-center partnership revenue from anchor relationships such as the Advanced Simulation Centre established with the Montreal Heart Institute in February 2026. Go-to-market is enterprise field sales combined with structured presence at structural heart congresses, training villages, and advisory boards. Current operating geographies span Switzerland, Germany, and the United States, with growing presence in Canada, Brazil, and Puerto Rico via the Montreal Heart Institute ecosystem. The company has raised a €10 million growth-equity round from healthcare-specialist private-equity firm SHS (March 2023) to accelerate commercialization.

Name

Simulands

Legal name

Simulands AG

Website

https://simulands.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

Simulands AG is a Zurich-based medical device company that develops high-fidelity, patient-derived cardiovascular simulators for training interventional cardiologists and supporting medical device OEMs in structural heart therapy adoption.

Ownership category

akta.pro rank

Product category

Medical Simulation Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Structural Heart Valves (TAVR/SAVR) & Valve Repair (HLAHAFAB)

Keywords

• Cardiovascular simulators
• Medical simulation training
• Structural heart education
• Transcatheter procedure training
• Surgical simulation devices

Headquarters

HQ city

Zürich

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations

Revenue model

1. Simulator Hardware Sales: Sale of cardiovascular simulation platforms (simuGO, simuDRY, simuSLICE, simuPULSE product lines) for procedural training, sales demonstrations, and R&D applications.
2. Disposable Products: Single-use anatomical components including valves, leaflets, chambers, and fossa inserts. Designed for consistent performance, hygienic repetition, and reproducible training sessions.
3. Training Center Partnerships: Establishment of advanced simulation centers with partner institutions like Montreal Heart Institute, enabling ongoing training programs for structural heart interventions.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

Simulands manufactures and sells modular cardiovascular simulation hardware platforms for training cardiologists in structural heart procedures (TAVR, T-TEER, TMVR, LAAO, transseptal). The portfolio spans four product lines — simuGO, simuDRY, simuSLICE, and simuPULSE — using proprietary simuTISSUE material and patient-derived anatomy from real CT and 3D echo data, with accompanying disposable valve components and real-device compatibility.

Product overview

Simulands develops a modular cardiovascular simulation platform consisting of four simulator product lines (simuGO, simuDRY, simuSLICE, simuPULSE), disposables, and lifestyle merchandise. The simuGO line provides ultra-portable, travel-ready simulators for sales demos and field demonstrations. The simuDRY line offers dry, portable, modular training platforms for basic procedural skills targeting specific anatomies. The simuSLICE line delivers wet-lab simulators with imaging compatibility and device learning for pulsating anatomy movement. The simuPULSE line provides full beating-heart simulators with hemodynamic flow, body temperature, and the most realistic human-grade experience for implant training. Disposables include valve models (mitral, aortic, tricuspid) in various pathologies for use across simulator platforms. All products are designed from real patient data and are compatible with real medical devices, supporting TEE, ICE, and fluoroscopy imaging. The company was founded in 2019 in Zurich, Switzerland.

Differentiator

Problem solved

Functional benefit

Brands

• simuGO: Ultra-portable, travel-ready simulators for on-the-go sales demos and quick hands-on procedural experience. Includes simuGO Aortic and simuGO LAA products.
• simuDRY
• simuSLICE
• simuPULSE
• simuTISSUE
• simuVISION
• simuCANDLE
• simuJACKET
• simuCAN

Products and services

• simuGO Aortic Compact portable simulator that replicates the aortic valve environment for hands-on device navigation, positioning, and deployment in TAVR procedures. Features transparent chamber for direct visualization and setup in under 30 seconds, designed for sales demos and field training.
• simuGO LAA Real-device-ready portable platform for training transseptal puncture and Left Atrial Appendage Occlusion (LAAO) device access, positioning, and deployment across anatomies. Optimized for field demos, hospital training, and therapy onboarding.
• simuDRY Mitral Dry, portable, human-grade simulator for transcatheter mitral valve repair and replacement (TEER and TMVR) training. Features modular anatomies with DMR and FMR pathologies, interchangeable valve inserts, and real-device compatibility.
• simuDRY Transseptal Dry, portable human-grade simulator for mastering transseptal access. Built from patient CTs and 3D echo datasets with tactile septum response and multiple fossa disposables (regular, floppy, thick, PFO, ASD).
• simuDRY Tricuspid Dry portable simulator for tricuspid edge-to-edge repair and transcatheter replacement therapies. Replicates patient-specific anatomy with modular setups for common and advanced scenarios, featuring human-grade disposable valve and ventricle.
• simuSLICE Atrial Compact, high-fidelity wet-lab platform for mastering transseptal puncture, LAAO workflows, and structural heart access procedures. Features CT-derived LA anatomy with motion and flow, compatible with real devices and imaging.
• simuSLICE Mitral Beating-heart, high-fidelity simulator for mitral procedural training, human factors testing, and live demonstrations. Built from CT and 3D echo of real DMR and FMR patients with motorized annular motion and water-filled environment.
• simuSLICE Tricuspid High-fidelity, motion-enabled training platform for mastering TEER and TTVR systems in tricuspid therapies. Features patient-based right heart anatomy with adjustable heart rate, leaflet motion, and full imaging compatibility.
• simuPULSE Aortic High-fidelity pulsatile simulator for training, demonstration, and device evaluation in Transcatheter Aortic Valve Therapies (TAVI). Features anatomically complete left heart system with pressure, flow, and temperature control, plus multi-camera imaging.
• simuPULSE Access Full human-grade access platform to train and evaluate femoral entry and closure, large-bore management, vascular plug deployment, bleeding control, and sheath techniques under physiological pressure with realistic haptics.
• simuPULSE Mitral TA Dynamic mitral valve simulation platform for T-TEER, TMVR, and structural interventions with real-time physiological flow, imaging compatibility, and modular patient-derived anatomy. Features pulsatile heart rate (40-80 bpm) and body temperature water bath.
• simuPULSE Mitral TF Full beating-heart platform for Transcatheter Mitral Valve Repair and Replacement therapies with real-device interaction, multimodal imaging, and modular human-grade anatomy. Features left heart system with LA, MV, LV, chordae, and adjustable cardiac flow.
• simuPULSE Tricuspid High-fidelity, right-heart simulator for hands-on training, real-device deployment, and procedural education in Tricuspid Valve Repair and Replacement. Features human-grade anatomy, interchangeable disposable valves, and 4-camera system with body temperature simulation.
• simuPULSE Imaging First-ever full-heart, 4-chamber beating simulator crafted entirely in fluorogenic and echogenic material. Built for structural heart training enabling hands-on procedural imaging under TEE, ICE, and fluoroscopy without digital overlay.
• DRY Mitral Valve FMR Silicone-based Functional Mitral Regurgitation (FMR) valve with aortic valve landmark, designed as a single-use disposable component for DRY simulators.
• DRY Tricuspid Valve Apparatus Soft compliant tricuspid valve with chordae tendineae and papillary muscles, designed as a disposable component for simuDRY Tricuspid.
• PULSE Mitral Valve Soft compliant mitral valve molded for pre-set or adjustable pathology options, designed as a disposable component for simuPULSE Mitral.
• PULSE Aortic Valve H High calcification aortic valve disposable (Perimeter 86mm, Area 582mm2) designed for simuPULSE Aortic.
• PULSE Mitral Valve FMR Small Small silicone-based Functional Mitral Regurgitation valve (CC 32.6mm, AP 20.8mm) with approximately 20 uses, designed as a disposable component for simuPULSE Mitral TF.
• PULSE Tricuspid Valve FTR S Small silicone-based Functional Tricuspid Regurgitation valve (Septal-lateral 41mm, Perimeter 128mm, Area 13.2cm2) designed as a disposable component for simuPULSE Tricuspid.

Quantifiable outcome

• Montreal Heart Institute aims to double the number of valve disease patients treated by 2028 through accelerated specialist training
• +1 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Surgical Science: Surgical Science is a leading provider of virtual reality surgical simulation and training solutions, with a strong presence in endovascular and minimally invasive procedure training. Directly comparable to Simulands in selling high-fidelity simulators to hospitals and medical device companies for procedural training.
• Mentice: Mentice specializes in endovascular and interventional cardiology simulation, including structural heart procedures such as TAVR. Like Simulands, it serves hospitals and medical device OEMs with realistic training platforms that incorporate imaging and real-device compatibility.
• VirtaMed: VirtaMed develops high-fidelity simulators for arthroscopy, laparoscopy, OB/GYN, and urology, and has expanded into cardiovascular training. Similar to Simulands in targeting procedural training with anatomically realistic models used by both hospitals and medical device companies.

Broad incumbents

• CAE Healthcare: CAE Healthcare is the medical division of CAE Inc., offering a broad portfolio of patient simulators, surgical simulators, and ultrasound training systems. Comparable to Simulands as a major medical simulation player but operating across many specialties beyond structural heart.
• Laerdal Medical: Laerdal Medical is one of the largest medical simulation companies globally, focused on resuscitation, emergency care, and patient simulation. Comparable as a major medical training solutions provider serving hospitals and educational institutions, though less specialized in structural heart.
• 3D Systems (Simbionix): 3D Systems' Simbionix division offers virtual reality surgical simulators across multiple specialties. Comparable to Simulands as a broader procedural simulation player with hospital and OEM customers, though not specialized in structural heart.

Emerging players

• Orzone (Operative Experience / Orsi Academy ecosystem): Operative Experience and similar firms provide hybrid physical-virtual surgical and endovascular simulators. Partially comparable to Simulands as an emerging player in procedure-specific high-fidelity simulation for medical training.
• Limbs & Things: Limbs & Things produces task-based clinical skills and procedural trainers for medical education. Partially comparable to Simulands in providing anatomical training models to hospitals and medical schools, though less specialized in cardiovascular beating-heart simulation.

Others

• Edwards Lifesciences: Edwards Lifesciences is the leading transcatheter aortic valve (TAVR) manufacturer and a primary buyer of physician training tools. Comparable to Simulands as a customer-side partner in the structural heart ecosystem that drives demand for procedural simulators.
• Abbott Vascular: Abbott's structural heart division (acquired from St. Jude Medical) makes MitraClip and other transcatheter mitral/tricuspid therapies. Comparable to Simulands as a major customer-side counterpart requiring physician training and product demonstration platforms.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/simulands

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Simulands